KRT18 and breast carcinoma: HCT-116, SCID mice with FaDu human tumor xenografts, C57BL/6J mice with syngenic LLC tumor, BALB/C mice with orthotopic breast carcinomas (4T1), Xenograft-derived CK18 in circulation